SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-18-009610
Filing Date
2018-07-02
Accepted
2018-07-02 19:48:26
Documents
1
Period of Report
2018-06-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4253
  Complete submission text file 0001493152-18-009610.txt   5805
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Reporting) CIK: 0001542484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 18934459